Update shared on 16 Nov 2025
Fair value Decreased 0.79%Analysts have slightly lowered their price target for Healthpeak Properties from $21.03 to $20.86. They cite modest adjustments in growth and discount rate assumptions, while also noting a marginal improvement in profit margins.
What's in the News
- From July 1, 2025 to September 30, 2025, Healthpeak Properties repurchased 0 shares for $0 million. This action completed the overall buyback of 5,091,156 shares for $94.17 million announced on July 25, 2024 (Key Developments).
- Healthpeak Properties, Inc. (NYSE: DOC) has been removed from the FTSE All-World Index (USD) (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has decreased slightly from $21.03 to $20.86 per share.
- Discount Rate has dropped marginally from 8.25% to 8.22%.
- Revenue Growth forecast has moderated, moving from 3.33% to 3.32%.
- Net Profit Margin shows a modest improvement, rising from 6.19% to 6.23%.
- Future P/E ratio has declined slightly, shifting from 95.00x to 93.59x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.